TREE NEWS update: Walmart beat Q2 FY2027 revenue and adjusted EPS expectations, but US same-store sales grew only 2.6%, the slowest in over six years, due to pharmacy price deflation. The company raised its full-year guidance, yet the adjusted EPS upper end remained below consensus, signaling slowing momentum.
Walmart Q2 FY2027: Revenue and EPS Beat, US Same-Store Sales Slowest in Six Years
The headline beat masks a divergence: Walmart's raised guidance still caps adjusted EPS below consensus, so the profit outlook is being trimmed even as revenue holds. The drag is pharmacy price deflation, a structural pricing effect rather than a demand problem, which makes the 2.6% same-store figure less alarming than the six-year low suggests. The open question is whether pharmacy deflation keeps suppressing reported comps, or whether underlying traffic and general merchandise offset it in coming quarters.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.